CompuMed to bring OsteoGram to China

Bone density firm CompuMed has received approval from China's State Food and Drug Administration (SFDA) for its OsteoGram bone density screening software.

CompuMed received clearance to market OsteoGram for screening, diagnosing, and monitoring osteoporosis, according to the Los Angeles-based firm. CompuMed said it would work with Chinese OEMs to target the market.

Related Reading

CompuMed wins Arizona ECG contract, July 10, 2008

CompuMed teams with Osteometer MediTech, May 29, 2008

CompuMed wins West Virginia contract, May 1, 2008

CompuMed unveils new features for OsteoGram, November 27, 2007

CompuMed advances revenues in Q3, August 15, 2007

Copyright © 2008 AuntMinnie.com

Page 1 of 376
Next Page